selesyn 100 micrograms/2 ml, oral solution (50 micrograms/ml)
biosyn arzneimittel gmbh - selenium - oral solution - 100 µg/2ml - selenium; sodium selenite
selesyn 500 micrograms/10 ml, oral solution (50 micrograms/ml)
biosyn arzneimittel gmbh - selenium - oral solution - 500 microgram(s) - selenium; sodium selenite
selesyn 100 micrograms/2 ml, solution for injection (50 micrograms/ml)
biosyn arzneimittel gmbh - selenium - solution for injection - 100 µg/2ml - selenium; sodium selenite
selesyn 500 micrograms/10 ml, solution for injection (50 micrograms/ml)
biosyn arzneimittel gmbh - selenium - solution for injection - 500 microgram(s) - selenium; sodium selenite
selenase t pro injectione solucion inyectable
biosyn arzneimittel gmbh - selenio (selenito sodico pentahidratado) - selenio (selenito sodico pentahidratado)....500 µg
cefuroxime dr. eberth 750 mg powder for solution for injection/infusion
dr. friedrich eberth arzneimittel gmbh am bahnhof 2, ursensollen 92289, germany - cefuroxime sodium - powder for solution for infusion or injection - cefuroxime sodium 750 mg - antibacterials for systemic use
cefuroxime dr. eberth 1500 mg powder for solution for injection/infusion
dr. friedrich eberth arzneimittel gmbh am bahnhof 2, ursensollen 92289, germany - cefuroxime sodium - powder for solution for infusion or injection - cefuroxime sodium 1500 mg - antibacterials for systemic use
selenase t peroral solucion oral
biosyn arzneimittel gmbh - selenio (selenito sodico pentahidratado) - selenio (selenito sodico pentahidratado)....50 µg
befibrat 400mg retard film-coated tablets
hennig arzneimittel gmbh & co kg liebigstrasse 1-2, d-65439 flörsheim am main, germany - bezafibrate - film-coated tablet - bezafibrate 400 mg - lipid modifying agents
cholestagel
cheplapharm arzneimittel gmbh - colesevelam (as hydrochloride) - hypercholesterolemia - lipid modifying agents - cholestagel co-administered with a 3-hydroxy-3-methyl-glutaryl-coenzyme-a (hmg-coa)-reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in low-density-lipoprotein-cholesterol (ldl-c) levels in adult patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone.cholestagel as monotherapy is indicated as adjunctive therapy to diet for reduction of elevated total cholesterol and ldl-c in adult patients with primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated.cholestagel can also be used in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia (see section 5.1).